My research is at the intersection of genomics and computing, with a core emphasis on variant and copy number analysis, gene expression, microbiome, and proteomics studies. My current endeavors revolve around identifying genomic signatures and protein targets for drug discovery in movement disorders, particularly Dystonia and Parkinson’s Disease. My involvement extends to other significant initiatives, including disease modeling using Induced Pluripotent Stem Cells (iPSCs) for Lesch-Nyhan disease and DYT1 dystonia within the Hess-Jinnah Research Group.

2024 Publications

  • Annals of Neurology
    Blood-Based Proteomics for Adult-Onset Focal Dystonias.
  • Journal of Clinical Investigation
    Chronic SIV-Induced neuroinflammation disrupts CCR7+ CD4+ T cell immunosurveillance in the rhesus macaque brain.
  • Parkinsonism & Related Disorders
    Exploration of potential immune mechanisms in cervical dystonia.
  • Movement Disorders
    An Exploratory, Randomized, Double-Blind Clinical Trial of Dipraglurant for Blepharospasm.